• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • Subscribe newsletter
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: Featured Articles

Featured Articles

Navigating the increasing complexity of pancreatic disease: insights from a PENTAX Medical expert

, 29 January 2025/in Featured Articles /by panglobal

Pancreatic cancer poses a growing challenge in healthcare, defying the trend of declining cancer mortality rates. As the only cancer with increasing incidence rates across both genders, pancreatic cancer has risen to become the third leading cause of cancer-related death in Europe .

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/01/Jan-Nagel_1-scaled.jpg 2560 1707 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-01-29 13:50:472025-01-29 15:20:26Navigating the increasing complexity of pancreatic disease: insights from a PENTAX Medical expert
Alex Fong, Insights and Sustainability Lead at Owen Mumford

Embedding sustainable principles in the design of drug delivery devices

drug delivery device, 21 December 2024/in Drug delivery, Featured Articles, Sustainability /by panglobal

Alex Fong, Insights and Sustainability Lead at Owen Mumford, explores how life-cycle assessment (LCA) is transforming the design of drug delivery devices. With single-use auto-injectors generating 400g CO₂e per unit, Fong presents innovative approaches to reduce environmental impact while maintaining critical safety standards.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/12/Alex-Fong-.jpeg 800 800 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-12-21 08:31:252024-12-21 08:31:25Embedding sustainable principles in the design of drug delivery devices
Siemens_Healthineers_Naeotom Alpha CT

Siemens expands photon-counting CT portfolio with new class of scanners

CT, Naeotom Alpha, photon counting, 10 December 2024/in Computed Tomography, Editors' Picks, Featured Articles, Imaging, Product News /by panglobal

Three years after launching the world’s first photon-counting computed tomography scanner, Siemens Healthineers has expanded its portfolio with two new systems: the dual-source Naeotom Alpha.Pro and the single-source Naeotom Alpha.Prime. These innovations promise enhanced diagnostic capabilities through superior image quality at lower radiation doses, with potential to change clinical pathways. Callan Emery attended the launch […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/12/Siemens_Healthineers_Naeotom-Alpha-CT-scaled.jpg 1129 2560 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-12-10 13:49:422025-04-02 09:36:53Siemens expands photon-counting CT portfolio with new class of scanners
extreme heat

Five ways that climate change threatens human health

climate change, COP29, 18 November 2024/in Climate Change, Featured Articles /by panglobal
Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/11/extreme-heat.jpg 628 1100 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-11-18 11:38:392024-11-18 11:38:39Five ways that climate change threatens human health
Fabio Zaniboni

How IoT can automate compliance, cut energy costs and improve patient care

CO2 emissions, Internet of Things, smart building, smart technologies, 6 November 2024/in AI, Featured Articles, Hospital Design, MedTech, Sustainability /by panglobal

In this insightful analysis, Fabio Zaniboni, Founder & Chief Vision Officer at BubblyNet, examines how Internet of Things (IoT) technology is revolutionizing hospital operations. Drawing from over two decades of experience in IoT and digital transformation, Zaniboni demonstrates how smart building solutions can simultaneously reduce energy consumption, automate regulatory compliance, and enhance patient outcomes through […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/11/Fabio-Zaniboni.jpg 1207 960 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-11-06 08:32:412024-11-06 08:32:41How IoT can automate compliance, cut energy costs and improve patient care
Dr. Feras Khaliel

The world’s first fully robotic heart transplant: We interview the cardiac surgeon about the procedure

heart transplant, KFSHRC, Robotics, world-first, 8 October 2024/in Cardiology, Featured Articles, MedTech, Surgery /by panglobal

In an historic achievement, Dr. Feras Khaliel and his team at King Faisal Specialist Hospital & Research Centre (KFSHRC) in Riyadh, Saudi Arabia, successfully performed the world’s first fully robotic heart transplant on a 16-year-old patient with end-stage heart failure. This innovative procedure reduced recovery times and surgical risks, setting a new standard for cardiac […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/10/Dr-Feras-Khaliel_1.jpg 1009 2000 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-10-08 11:27:402024-10-08 11:27:40The world’s first fully robotic heart transplant: We interview the cardiac surgeon about the procedure
donanemab Kinsula

FDA under fire: Controversial Alzheimer’s drug donanemab approved amid excess death concerns and conflicts of interest

Alzheimer’s, donanemab, Eli Lilly, FDA, The BMJ, 26 September 2024/in dementia, E-News, Editors' Picks, Featured Articles, Patient Safety, pharmacology, Regulation /by panglobal

A new investigation of FDA-approved Alzheimer’s drug donanemab highlights concerns about excess deaths, missing safety data, and financial conflicts of interest among FDA advisory panel members who recommended approval.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/09/donanemab_kinsula_web.jpg 800 1200 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-09-26 02:00:412024-09-25 13:29:05FDA under fire: Controversial Alzheimer’s drug donanemab approved amid excess death concerns and conflicts of interest
antimicrobial resistance

Antibiotic-resistant infections set to claim millions of lives by 2050, global study warns

antimicrobial resistance, future projections, infection, study, 23 September 2024/in E-News, Editors' Picks, Featured Articles /by panglobal

A groundbreaking analysis published in The Lancet predicts a steep rise in deaths from antimicrobial resistance, with older adults most at risk. The study offers a stark reminder of the urgent need for global action to combat this growing threat.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/09/AMR.jpg 784 1045 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-09-23 10:39:222024-09-23 10:39:22Antibiotic-resistant infections set to claim millions of lives by 2050, global study warns

Groundbreaking technique renders skin transparent, opening new avenues for diagnostic imaging

diagnostics, food dye, skin, tartrazine, transparent, 5 September 2024/in E-News, Editors' Picks, Featured Articles, Imaging /by panglobal

Researchers have developed a novel method to make skin and underlying tissues transparent using a common food dye, heralding potentially far-reaching applications for a wide range of medical diagnostics and certain treatments.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/09/transparent_skin_2.jpg 1080 1920 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-09-05 20:01:592024-09-06 08:29:58Groundbreaking technique renders skin transparent, opening new avenues for diagnostic imaging
COVID-19 virus

New antibody neutralises all known SARS-CoV-2 variants

antibody, COVID-19, immunity, Research, SARS-CoV-2, SC27, 4 September 2024/in COVID 19, E-News, Editors' Picks, Featured Articles /by panglobal

A broadly neutralising antibody capable of protecting against all known SARS-CoV-2 variants and related coronaviruses has been discovered by researchers at the University of Texas at Austin.  

Read more
https://interhospi.com/wp-content/uploads/sites/3/2024/09/covid_virus.jpg 798 800 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2024-09-04 14:44:362024-09-04 14:44:36New antibody neutralises all known SARS-CoV-2 variants
Page 2 of 102‹1234›»

Latest issue of International Hospital

April 2024

27 June 2025

Scientists launch world first project to create synthetic human genome with £10mn Wellcome funding

27 June 2025

GE HealthCare advances precision imaging with MIM Encore platform

27 June 2025

GE HealthCare advances cardiac PET diagnostics with Flyrcado launch

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription